Day: October 7, 2025

Owlstone Medical wins up to $49.1M ARPA-H award to pioneer breath-based cancer detection

Owlstone Medical wins up to $49.1M ARPA-H award to pioneer breath-based cancer detection UK medtech Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the Platform Optimising SynBio for Early Intervention and Detection in Oncology (POSEIDON https://arpa-h.gov/explore-funding/programs/poseidon program. 

Sylvia Health takes on a global women’s health crisis

Sylvia Health takes on a global women’s health crisis Pelvic organ prolapse is a common but often stigmatised condition in which one or more of the organs in the female pelvis descend into, or out of, the vagina. It can cause pain, discomfort, and significant emotional distress, disrupting women’s ability

FBI cyber threat adviser Filigran raises $58M

FBI cyber threat adviser Filigran raises $58M French cybersecurity startup Filigran, whose clients include the FBI and the European Commission, has raised $58m in a funding round, meaning it has now raised over $100m since its inception three years ago. The Series C funding round was led by French investment

Bologna Gathering showcases Italy’s rising innovation momentum

Bologna Gathering showcases Italy’s rising innovation momentum Last month, I attended The Bologna Gathering, a curated event bringing 300 selected innovation leaders to Italy. Bologna is a city in Northern Italy and the capital of the Emilia-Romagna region.  The event represents an increased effort to host tech events beyond capital

September 2025’s top 10 European tech deals you need to know about

September 2025’s top 10 European tech deals you need to know about In September 2025, European tech companies raised €8.4 billion, up 163 per cent from August’s €3.2 billion and roughly double September 2024’s €4.2 billion. Deal activity also increased, with 367 transactions, a 94 per cent jump from August

TRIBBU takes the wheel: €2 million boost for Spanish startup to end the lonely commute and tackle carbon emissions

TRIBBU takes the wheel: €2 million boost for Spanish startup to end the lonely commute and tackle carbon emissions Madrid-based carpooling platform TRIBBU, formerly known as Hoop Carpool, has raised over €2 million in a fresh funding round to transform daily commutes in Spain through efficient, sustainable, and community-powered mobility.

London’s VC-backed Agio Ratings lands €5 million to support banks entering the crypto market

London’s VC-backed Agio Ratings lands €5 million to support banks entering the crypto market Agio Ratings, a British source of risk insights in digital assets, has closed a €5 million funding round to expand its research and engineering teams, broadening the scope of its risk ratings and supporting banks as

Spanish ClimateTech startup Clevergy raises €3.2 million to scale its smart energy platform across Europe

Spanish ClimateTech startup Clevergy raises €3.2 million to scale its smart energy platform across Europe Madrid-based ClimateTech startup Clevergy has raised €3.2 million to accelerate its international expansion after tripling its growth last year. The round was co-led by Racine² (managed by Serena and Makesense) and Axon Partners Group, with

France’s Filigran nets €49 million to scale cyber defence solutions used by the FBI and European Commission

France’s Filigran nets €49 million to scale cyber defence solutions used by the FBI and European Commission Cybertech company Filigran hailing from Paris has completed a Series C funding round worth €49 million, bringing its total fundraising to over €85 million in just three years since its founding. This fundraising

Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments

Edinburgh-based BioTech Trogenix lands €80 million to accelerate curative cancer treatments Trogenix Ltd, a Scottish BioTech company dedicated to innovative cancer therapies, announced the completion of its Series A financing, raising €80 million, to advance its pipeline of potentially curative cancer therapies across multiple aggressive solid tumours. The Series A